Breast Cancer Clinical Trial
Official title:
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
What's the purpose of this study? This 4-year study is designed: (1) to teach primary care
physicians how to recognize low health literacy patients and effectively counsel them on
cancer screening using risk communication and shared decision making and (2) to assess the
impact of training on changes in physician communication behavior and changes in low health
literacy patients' cancer screening behaviors. This study proposal is based on the
hypothesis that physician training in cancer screening guidelines, health literacy, and
communication skills will improve provider-patient interactions during encounters dealing
with preventive health maintenance especially cancer screening.
How will the proposed study be implemented? Thirty-two physicians in the New Orleans
metropolitan area will be recruited and randomly assigned to one of two groups. The unit of
randomization will be the health care organization or clinic. The intervention group will
receive training in health literacy, cancer screening, risk communication and shared
decision-making. The control group will not receive communication training until the end of
the study. Physicians in both groups will undergo three clinic visits with standardized
patients (actors trained to portray real patients; mystery shoppers) but they will not be
aware that they are conducting visits with actors. The visits will occur at study enrollment
and at 6 and 12 months. At the end of each clinic visit, the standardized patients will rate
the physicians' communication skills. Each physician assigned to the intervention group will
receive verbal feedback on communication skills from the standardized patients and complete
a web-based tutorial. Physicians in the control group will not have access to the web-based
tutorial until the end of the study.
For each physician, 10-15 patients with limited health literacy will be recruited to the
study. Each patient will rate his/her perceived involvement with care and global
satisfaction with care at study enrollment and annually for three years. Age and
gender-appropriate referral rates for breast, cervical and colorectal cancer screening and
patients' receipt of such screening will be assessed annually for three years. All study
physicians, regardless of group assignment, will receive performance feedback (report cards)
on their cancer screening rates among low health literacy patients in their clinic.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |